Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Jul 2022 for Cumberland Pharmaceuticals INC, €65k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Leo Pavliv: trading record in brief
Leo Pavliv, listed as senior executive, appears in our data through filings on Cumberland Pharmaceuticals Inc shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 17 March 2021 and the latest from 31 May 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 1 July 2022: a transaction of €65k, in Cumberland Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Leo Pavliv
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
33,500 shares@ US$2.090.080% mcap80.8% of flowCommon StockSEC:0001209191-22-040113:0
2,870 shares@ US$3.2210.6% of flowCommon StockSEC:0001209191-21-039925:0
2 of 2 declarations
